Clinical Trials Directory

Trials / Completed

CompletedNCT00559598

Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer

Use of Serum Proteome on the Early Diagnosis of Malignant Biliary-Pancreatic Disease

Status
Completed
Phase
Study type
Observational
Enrollment
502 (estimated)
Sponsor
National Institutes of Health Clinical Center (CC) · NIH
Sex
All
Age
Healthy volunteers
Accepted

Summary

RATIONALE: Studying samples of blood in the laboratory from patients with cancer and from healthy participants may help doctors identify and learn more about proteins related to cancer. It may also help doctors tell whether a patient has cancer. PURPOSE: This clinical trial is looking at proteins in blood samples to see how well they work in finding pancreatic cancer and extrahepatic biliary tract cancer.

Detailed description

OBJECTIVES: * To explore the utility of the serum proteome pattern for early detection and diagnosis of pancreatic and extraheptic biliary tract cancer by analyzing serum samples from participants previously enrolled in the PANKRAS-II study. * To support efforts to contact participants (recruited to the PANKRAS-II study 10 years ago) who were diagnosed with benign biliary-pancreatic disease in order to discern if they subsequently developed a malignant biliary-pancreatic tumor. * To gather information about clinical factors surrounding the date of blood extraction that may influence the proteomic patterns of the blood samples by performing a review of clinical records of participants. OUTLINE: Serum samples are analyzed for proteome pattern. Participants undergo a telephone interview about their medical history (i.e., pancreatic or biliary tract disease diagnosed within the past 10 years). Medical records are reviewed to gather information about clinical factors surrounding the date of blood extraction that may influence the proteomic patterns of the blood samples.

Conditions

Interventions

TypeNameDescription
GENETICproteomic profiling
OTHERmedical chart review

Timeline

Start date
2004-08-01
Completion
2009-04-01
First posted
2007-11-16
Last updated
2012-03-08

Source: ClinicalTrials.gov record NCT00559598. Inclusion in this directory is not an endorsement.